These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17459055)

  • 1. Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression.
    Oda Y; Ohishi Y; Basaki Y; Kobayashi H; Hirakawa T; Wake N; Ono M; Nishio K; Kuwano M; Tsuneyoshi M
    Cancer Sci; 2007 Jul; 98(7):1020-6. PubMed ID: 17459055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
    Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
    Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
    Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
    Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
    Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
    Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial-mesenchymal transition through targeting major vault protein (MVP).
    Lou L; Wang J; Lv F; Wang G; Li Y; Xing L; Shen H; Zhang X
    Cell Oncol (Dordr); 2021 Feb; 44(1):109-133. PubMed ID: 32894437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of multidrug resistance-related markers in primary neuroblastoma.
    Lu QJ; Dong F; Zhang JH; Li XH; Ma Y; Jiang WG
    Chin Med J (Engl); 2004 Sep; 117(9):1358-63. PubMed ID: 15377429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of phosphorylated protein kinase B and PTEN protein in ovarian epithelial cancer].
    Qiao YH; Cheng J; Guo RX
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):325-9. PubMed ID: 17673045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma.
    Kerr EH; Frederick PJ; Egger ME; Stockard CR; Sellers J; DellaManna D; Oelschlager DK; Amm HM; Eltoum IE; Straughn JM; Buchsbaum DJ; Grizzle WE; McNally LR
    Ann Surg Oncol; 2013 Sep; 20(9):3059-65. PubMed ID: 23525731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease.
    Triller N; Korosec P; Kern I; Kosnik M; Debeljak A
    Lung Cancer; 2006 Nov; 54(2):235-40. PubMed ID: 16934363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma.
    Oda Y; Kohashi K; Yamamoto H; Tamiya S; Kohno K; Kuwano M; Iwamoto Y; Tajiri T; Taguchi T; Tsuneyoshi M
    Cancer Sci; 2008 Apr; 99(4):726-32. PubMed ID: 18377424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples.
    Penson RT; Oliva E; Skates SJ; Glyptis T; Fuller AF; Goodman A; Seiden MV
    Gynecol Oncol; 2004 Apr; 93(1):98-106. PubMed ID: 15047220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma.
    Yasen M; Kajino K; Kano S; Tobita H; Yamamoto J; Uchiumi T; Kon S; Maeda M; Obulhasim G; Arii S; Hino O
    Clin Cancer Res; 2005 Oct; 11(20):7354-61. PubMed ID: 16243807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
    Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
    Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma.
    Khouja MH; Baekelandt M; Nesland JM; Holm R
    Int J Gynecol Pathol; 2007 Oct; 26(4):418-25. PubMed ID: 17885492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
    Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
    Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic value of the lung resistance-related protein (LRP) in germ cell testicular tumors.
    Mándoky L; Géczi L; Doleschall Z; Bodrogi I; Csuka O; Kásler M; Bak M
    Anticancer Res; 2004; 24(2C):1097-104. PubMed ID: 15154630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the lung resistance protein (LRP) in primary breast cancer.
    Pohl G; Filipits M; Suchomel RW; Stranzl T; Depisch D; Pirker R
    Anticancer Res; 1999; 19(6B):5051-5. PubMed ID: 10697509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomas.
    Levidou G; Korkolopoulou P; Thymara I; Vassilopoulos I; Saetta AA; Gakiopoulou H; Konstantinidou A; Kairi-Vassilatou E; Pavlakis K; Patsouris E
    Int J Gynecol Pathol; 2007 Oct; 26(4):410-7. PubMed ID: 17885491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.
    Filipits M; Drach J; Pohl G; Schuster J; Stranzl T; Ackermann J; Königsberg R; Kaufmann H; Gisslinger H; Huber H; Ludwig H; Pirker R
    Clin Cancer Res; 1999 Sep; 5(9):2426-30. PubMed ID: 10499614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species.
    Evdokimova V; Ruzanov P; Anglesio MS; Sorokin AV; Ovchinnikov LP; Buckley J; Triche TJ; Sonenberg N; Sorensen PH
    Mol Cell Biol; 2006 Jan; 26(1):277-92. PubMed ID: 16354698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.